FS

Francesca Stillitano

Utrecht Regenerative Medicine Center, University Medical Center Utrecht

Affiliated withUniversity Medical Center Utrecht

Research Area

Biography

Francesca Stillitano has not added Biography.
If you are Francesca Stillitano and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 7	2023

Other Publications

Article	Year
Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes. Stem cells translational medicine\| PubMed ID: 24324277	2014
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes. Stem cell research & therapy\| PubMed ID: 24405778	2014
Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy. Nature communications\| PubMed ID: 25923014	2015
Genomic correction of familial cardiomyopathy in human engineered cardiac tissues. European heart journal\| PubMed ID: 27450564	2016
Gene Transfer in Cardiomyocytes Derived from ES and iPS Cells. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 27910049	2017
Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells. eLife\| PubMed ID: 28134617	2017
Functional Human Beige Adipocytes From Induced Pluripotent Stem Cells. Diabetes\| PubMed ID: 28270520	2017
Exosomal microRNA-21-5p Mediates Mesenchymal Stem Cell Paracrine Effects on Human Cardiac Tissue Contractility. Circulation research\| PubMed ID: 29449318	2018
Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes. Journal of molecular and cellular cardiology\| PubMed ID: 29752948	2018
Cardiac Tissue Engineering Models of Inherited and Acquired Cardiomyopathies. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 29987817	2018
Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues. Stem cell research & therapy\| PubMed ID: 31801634	2019
Impaired Right Ventricular Calcium Cycling Is an Early Risk Factor in R14del-Phospholamban Arrhythmias. Journal of personalized medicine\| PubMed ID: 34204946	2021
Generation of human induced pluripotent stem cell (iPSC) lines derived from five patients carrying the pathogenic phospholamban-R14del (PLN-R14del) variant and three non-carrier family membe... Stem cell research\| PubMed ID: 35247838	2022
Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts. Metabolism: clinical and experimental\| PubMed ID: 36375644	2023
Myofilament Alterations Associated with Human R14del-Phospholamban Cardiomyopathy. International journal of molecular sciences\| PubMed ID: 36768995	2023